Agenda
Plenary Sessions
The Digital Lab
The Connected Innovation Lab
Networking Session
08:45
Welcome and Opening Remarks
Plenary Sessions
08:45 EST

Digital transformation has had significant support amongst our executive leadership. The last 18 months has also seen considerable investment being made in technology, upskilling and processes to ensure our labs are fit for modern biopharma research.

However, we are still facing some fundamental challenges in transitioning to a truly digital and data driven industry. Not least are legacy systems, poor data quality, disconnected datasets, lack of skills and archaic, siloed, working practices.

How are our leaders addressing these important challenges and what lessons have they learnt from their own internal initiatives? More importantly, what advice and guidance can they give us to ensure that our scientists have the tools at their fingertips to allow them to innovate in a digital world.

09:00
Driving Innovation and Patient-Centricity in Drug Development Using Digital Technologies
Plenary Sessions
09:00 EST
Lisa Shipley, former VP Digital and Analytics Technologies, Merck
  • Challenges in drug development and opportunities for digital
  • Current state of digital endpoint use in trials
  • How digital technologies, such as wearables and sensors, are transforming clinical trials
  • The shifting regulatory environment
  • Challenges for implementation
  • Precompetitive Collaboration – how can we work together to advance the field?
09:20
Enabling digital transformation with the use of IoT connectivity and platform technology
Plenary Sessions
09:20
Adam Wheeler, Customer Enablement, Digital Solutions, Thermo Fisher Scientific
Matt Gafencu, Senior Customer Success Manager, Amazon Web Services

Improving the customer experience with innovative technologies and enhancements
Modernizing legacy applications to drive valuable data insights
Leveraging platform technology to drive laboratory orchestration
Empowering data integrity and the value of streamlining processes and workflows
Driving scientific discoveries with the support of laboratory automation and integration

10:00
Lab of the Future – Empowering the Scientists through Digital Tools
Plenary Sessions
10:00 EST
Dimitris Agrafiotis, VP, Digital, Worldwide Research, Development and Medical, Pfizer
10:20
Digitalisation from Source to Scientist – Developing a data and technology driven flexible lab operations model
Plenary Sessions
10:20 EST
Tola Olorunnisola, VP, Strategy, Innovation, Marketing and Digital, Avantor
  • From Just in time to Just in Case, finding the right balance in a sustainable world? Market developments impacting the (lab) supply chain
  • Using data and Technology for science – from new era e-procurement to custom marketplaces and from IoT to AI powered inventory management
  • Creating a prescriptive end-2 end supply chain right to the point of experiments
11:00
Networking Coffee Break in Exhibition Area
Networking Session
11:00 EST
11:40
Digital Transformation in action
The Digital Lab
11:40 EST
Kristen Ferrara, Global Head of Scientific Informatics; R&D / Vaccines IT and Digital, Takeda
Adam Wheeler, Customer Enablement, Digital Solutions, Thermo Fisher Scientific

Developing a Data and Digital Journey for Research in the Lab

  • Setting the foundation, getting Data on the Cloud
  • Identifying the Now; do we know where we are
  • Chosing the Focus; defining the strategy for the future state
  • Driving the Transformation; the work to get to the future state
  • Continuous Evolution; Keeping the labs in the future

Kristen Ferrara, Global Head of Scientific Informatics; R&D / Vaccines IT and Digital, Takeda

Building a comprehensive digital strategy

  • Building a comprehensive digital strategy that leads to laboratory orchestration
  • Incorporating digital technologies to achieve a fully connected ecosystem
  • Driving industry evolution and the next set of digital transformation goals

Adam Wheeler, Customer Enablement, Digital Solutions, Thermo Fisher Scientific

Building the Lab of the Future – people, process and technology
The Connected Innovation Lab
11:40 EST
Vicky Pirzas, Managing Director R&D, CSL Behring Innovation
Bob Gantzer, Director of Lab Automation, Beam Therapeutics
David Fuller, CEO & Co-Founder, Artificial

Creating Space for Innovation
Lab of the future program at CSL spanning 3 continents.
The session will also include how robotics and automation and discussion around the type of workforce need for the future.

Vicky Pirzas, VP Recombinant Product Development, Managing Director R&D, CSL Behring Innovation


The Digital Lab – Convergence of the Internet and Industry 4.0

Embracing fundamental concepts from Industry 4.0
The Connected Lab
Laying the foundation for AI technologies

Bob Gantzer, Director of Lab Automation, Beam Therapeutics
David Fuller, CEO & Co-Founder, Artificial

12:40
Lunch & Networking in the Exhibition Area
Networking Session
12:40 EST
.,

Sponsored by:

13:40
Cross Stakeholder Collaboration and the Emerging Science and Technologies that will Drive Innovation in Biopharma research
Plenary Sessions
13:40 EST
Mike Snowden, Senior Vice President, AstraZeneca
14:20
Achieving Seamless Digitalisation from the Research Lab to Manufacturing
The Digital Lab
14:20 EST
Yves Fomekong Nanfack, Director, Head of Operations Digital Biologics Platform, Sanofi
Vasu Rangadass, President & CEO, L7 Informatics

Global Digital Strategy for Biologics at Sanofi
Digital Foundation for biologics
Platform and Systems
Scientific innovation Workstream
Dr. Yves Fomekong Nanfack, Director, Head of Operations Digital Biologics Platform, Sanofi

14:30 EST
Data + Intelligence for Scientific Enterprises

Digital Transformation for Life Science Operations
The Unified Data Model
Recent Case Studies
Vasu Rangadass, President and CEO, L7 Informatics

Digital Lab Operations and Procurement
The Connected Innovation Lab
14:20 EST
Mark Burfoot, VP Senior Partner, Head of Research Procurement, Novartis
Scott Streeseman, Director, Lab and Production Services, Avantor

Leveraging the Digital Age in Procurement Supporting the Lab of the Future
A sourcing view of the future
Optimizing the traditional and the transition to new models
Leverage Digital approaches that partner the scientific needs with future designs
How to think about our impact and where to focus
Mark Burfoot, VP Senior Partner, Head of Research Procurement, Novartis

14:30 EST
The science to lab management: driving digitalization and lab operations

Even with the latest digital research tools and other advanced systems available today, organisations still find themselves hampered by the cost, time and effort it takes to efficiently manage lab operations and move treatments from discovery to delivery faster.
Scott Streeseman, Director – Lab and Production Services, Avantor

15:20
Afternoon Refreshments & Networking in the Exhibition Area
Networking Session
15:20 EST
15:50
Transforming Experimental Data Capture in the Lab
The Digital Lab
15:50 EST
Leah O’Brien, Senior Product Director, Development Lab Systems, GSK
Sridhar Iyengar, CEO & Founder, Elemental Machines

Development Labs of the Future: How do we get there from here?

  • There is tremendous potential to accelerate new medicines by harnessing the power of development laboratory data
  • We can’t cross the chasm between current reality and the vision in a single leap
  • In GSK, we are transforming experiment data capture to drive the Lab of the Future

Leah O’Brien, Senior Product Director, Development Lab Systems, GSK

Why Data Maturity is Essential to the Lab of the Future

  • How digital operations & lab managers can optimize their lab’s usage of data
  • Why legacy organizations face steeper hurdles to data maturity than nimble startups
  • How lab workflows and researchers will be impacted by the advance of artificial intelligence and automation

Noelle Strubczewski, Associate Director, Equipment Management and Reliability, Ultragenyx Pharmaceuticals
Sridhar Iyengar
, CEO & Founder, Elemental Machines

Embedding Sustainable Thinking in the Lab
The Connected Innovation Lab
15:50 EST
James Connelly, CEO, My Green Lab
Sriman Banerjee, Head of Packaging Development & Commercial Device Engineering, Takeda
Priya Vijeyakumar, CEO, Watt IQ

What can be learned from industry success stories
James Connelly, CEO, MY Green Lab

Case Studies from Takeda
Sriman Banerjee, Head of Packaging Development & Commercial Device Engineering, Takeda

16:40 EST
Digitalization and Connectivity on the Path to Net Zero
Priya Vijayakumar, CEO, Watt IQ

16:40
The BMS R&ED IT Digital Greenhouse
The Connected Innovation Lab
16:40 EST
Vijay Nair, Director R&D IT - Cell Therapy and Early Clinical Development, Bristol Myers Squibb

The BMS R&ED IT Digital Greenhouse – Transform & Accelerate the way we innovate

The Greenhouse is a safe place to innovate and grow ideas. It is a virtual space where R&ED IT can work closely with business users to experiment with technology to solve challenges and create new opportunities.

  • Concept to accelerate deployment of innovate ideas including Lab of the Future initiatives
  • Overview of formalized process to quickly experiment with ideas

Engage >> Shape >> Experiment >> Readout

  • Examples – Innovative ideas quickly evaluated using Digital Greenhouse
Regulatory Document Automation
The Digital Lab
16:40 EST
Chris Burns, Senior Manager, Pfizer

Regulatory document automation – freeing up the scientists by improving the submission applications process

17:10
Live Lab
Plenary Sessions
17:10 EST
Live Lab,

The Live Lab sessions are a series of interactive moderated discussion sessions, held in the exhibition and refreshment area, where physical attendees can gather to debate and discuss some of the pressing themes and big picture challenges to delivering the Lab of the Future

Live Lab session 1)
Moderated by Geoff Parker, Scimcon Pharma 2040 – Building the scientist of the future
Technology is changing the landscape of the lab dramatically, what does this mean for our scientist’s day to day work? What will ‘Scientists spending more time doing science’ mean in 10 or 20 years?

Live Lab Session 2)
Moderated by Roger Shaw and Joost van Kempen, Digital Lab Consulting  – “How to be ready for an AI & ML world”
What do people think is needed. Practical steps to getting there

Live Lab session 3)
Moderated by Roger Frechette, NPA Associates: Delivering the Lab of the Future – top 5 areas for cross industry collaboration
Focus on the common challenges that need to be addressed delivering a future proof lab. Identifying pre competitive problems that could be addressed collaboratively in order to find common solutions.

17:30
Networking Drinks Reception
Networking Session
17:30 EST
Sponsored By:,

Sponsored By

 

09:10
Creating a Patient-Driven, Science-First R&D Organization
Plenary Sessions
09:10 EST
Andy Plump, President, Research & Development, Takeda

There can be no greater mission than to achieve better health for our global citizens through innovation in medicine. How can we utilize technology and our internal research capabilities to translate our science into transformative medicines? How can we unify platforms and processes within the Lab of the Future to enable our scientists to deliver on this mission?

09:40
Digital Transformation Strategy
Plenary Sessions
09:40 EST
Kailash Swarna, Managing Director, Life Sciences, Accenture
  • The vision – where are we now and we would we like to be?
  • The strategy –  incorporating new science, technology and processes
  • Learnings to date
10:00
Delivering the Benefits of Digitalisation
Plenary Sessions
10:00 EST
Clive Higgins, Head of Connected Lab, MilliporeSigma
10:50
Coffee & Networking in the Exhibition Area
Networking Session
10:50 EST
Sponsored By,
11:30
Future Visions for the Lab
The Digital Lab
11:30 EST
Dan Paulson, Senior Enterprise Architect, AstraZeneca
Robin Brouwer, Digital Lab Capability Leader, AstraZeneca
Dana Vanderwall, Executive Director of Enterprise Informatics, Schrödinger

Digitization of the lab – AstraZeneca Case Study
What is our vision of a lab of the future
What are our focus areas for investment
What are our digital capabilities that underpin these focus areas

Dan Paulson, Senior Enterprise Architect, AstraZeneca
Robin Brouwer, Digital Lab Capability Leader, AstraZeneca

11:50 EST
Digital Chemistry in Action: The Lab of the Future is Less Lab

Optimizing the use of wet lab synthesis and assays
Utilising highly predictive computational models for design, ideation, collaboration, and project management
Case studies and success stories from drug discovery programs web agenda for bullet points

Dana Vanderwall, Executive Director of Enterprise Informatics, Schrödinger

Disruptive Innovation in Drug Discovery & Development
The Connected Innovation Lab
11:30 EST
Dom Hebrault, Digitalization Lead, Boehringer Ingelheim
Luigi Gentile, Chief Revenue Officer, BenchSci

Transformative R&D Technologies to Bring Innovative Medicines to Patients Faster
Computer-assisted synthetic planning for enhanced NCE production
From experiment planning to execution and data modeling
Automated integration of lab instrument data,
Building corporate knowledge and enabling data mining
The importance of scientific data architecture
The virtual lab companions
Dom Hebrault
, Digitalization Lead, Boehringer Ingelheim

Augmented Experiments – Using AI to shift R&D into a higher gear
The impact enterprise AI can have on an organization
Considerations to validate, introduce, and scale disruptive technology
How to transform your organization with AI today

Luigi Gentile, Chief Revenue Officer, BenchSci

12:30
Digital Use Case Session
The Digital Lab
12:30 EST
Shoh Asano, Principal Scientist, Pfizer
Peter Henstock, ML & AI Technical Lead, Pfizer

Image data analytics using virtualization, an on-premise, scalable microscopy case study

  • Modern microscopy often comes with an increase in image data size and analyses needs
  • Common fragmented computational infrastructure cannot scale well with these requirements
  • Presented here is an on-premise computational architecture based on virtualization
  • Real-life examples demonstrate the utility of such solution in our scientific environment

Shoh Asano, Principal Scientist, Pfizer

12:50 EST
Natural Language Processing – An assessment of current capabilities and opportunities for pharma

  • Review some recent advances that have completely changed the landscape of what’s possible
  • Provide some examples of how we can leverage the improved tools
  • Discuss the implications of these advances in the context of drug discovery

Peter Henstock, ML & AI Technical Lead, Pfizer

Taking Back Control – The democratization of data
The Connected Innovation Lab
12:30 EST
Douglas Scheesley, Scientific Leader, GSK
Richard Lee, Director Core Technology, ACD/Labs

My five critical learnings as a business owner of a drug development-wide ELN
Democratization of data; from novice to expert
Is it a tool for them or a toy for you?
Changing the ELN paradigm
If you cannot show them, you have lost them – working demos, not slides
Building enterprise solutions from the bottom-up
Douglas Scheesley, Scientific Leader, GSK

12:50 EST
Take Control of Analytical Data Marshaling…on Your Terms

Alternatives to black-box enterprise-level analytical data systems
Homogenized analytical data management dashboards
Managing analytical data marshaling and building workflows
Richard Lee, Director, Core Technology Innovation and Informatics Strategy ACD/Labs

13:30
Lunch & Networking in the Exhibition Area
Networking Session
13:30 EST
14:20
Digital Tools Empowering the Scientists
The Digital Lab
14:20 EST
Brendan Faherty, Principal Solutions Architect, Genentech
Evan Anderson, Manager, Data Architects, TetraScience

Empowering scientists through modern lab Informatics solutions
Delivering the benefits of shared and harmonised data
Brendan Faherty, Principal Solutions Architect, Genentech

Evan Anderson, Manager, Data Architects, TetraScience

How to get immediate and insights from R&D data
The Connected Innovation Lab
14:20 EST
Sally Madden, Bioinformatics Software Engineer, Genentech
Kara West, Lab Informatics Specialist, Millipore Sigma

The development and delivery of modern, data-centric, reusable and shareable software solutions at Genentech
Sally Madden, Bioinformatics Software Engineer, Genentech

14:40 EST
Topic to be finalised
Kara West
, Lab Informatics Specialist, MilliporeSigma

15:10
The path towards a modern research laboratory
The Digital Lab
15:10 EST
Brian Gilman, VP Research Technology, Vertex Pharmaceuticals
Cindy Novak, Senior Manager, Lab Computing Systems, Bristol Myers Squibb

Lab of the Future – tales from the trenches
Brian Gilman, VP Research Technology, Vertex

Implementing Robust Laboratory and Manufacturing Computerized Systems for Product Testing
Discuss importance of standardized imaging
Discuss system security
Discuss Validation/Qualification/Change Management
Discuss Maintenance/Periodic Monitoring
Cindy Novak, Senior Manager, Lab Computing Systems, Bristol Myers Squibb

Improving the efficiencies of lab workflows
The Connected Innovation Lab
15:10 EST
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai
Joseph Pease, Principal Scientific Manager, Genentech

Better Assay Development: Do it Like You’re Already Screening
Screening assays target repeatability, but the use of manual processes during the development phase can get in the way of that goal
Adding flexibility to workflows used for screening data capture to make them usable for assay development can help us do better science and reach the finish line faster
Jennifer Heymont, Associate Director, Scientific Informatics Eisai

15:30 EST
Sourcing Chemicals in the Lab of the Future

Development of a new system that streamlines the process for finding, ordering and delivering any commercially available chemical, including synthesis on demand
Leverage suppliers from around the world
Integration with internal systems and research workflows
Joseph Pease, Principal Scientific Manager, Genentech

16:00
The Connected Lab and IT Standards
The Connected Innovation Lab
16:00 EST
Tammy Muff, Director, Information Technology, Laboratory Computing Services, Bristol-Myers Squibb
Stuart Wonfor, Senior End to End Capability Service Manager, AstraZeneca
Kelly Randis, Director, IT Enterprise Architecture, Emerging Innovation, Bristol Myers Squibb
16:30
End of Lab of the Future USA and Closing Remarks
Plenary Sessions
16:30